Jeff Yass’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $48M | Buy |
88,579
+58,883
| +198% | +$33.2M | ﹤0.01% | 1543 |
|
|
2026
Q1 | $17.6M | Buy |
29,696
+16,004
| +117% | +$7.97M | ﹤0.01% | 2387 |
|
|
2025
Q4 | $6.67M | Sell |
13,692
-162,839
| -92% | -$75.8M | ﹤0.01% | 3596 |
|
|
2025
Q3 | $74M | Buy |
176,531
+153,265
| +659% | +$51.5M | 0.01% | 1076 |
|
|
2025
Q2 | $6.69M | Buy |
23,266
+16,625
| +250% | +$4.97M | ﹤0.01% | 3462 |
|
|
2025
Q1 | $2.05M | Sell |
6,641
-139
| -2% | -$47.6K | ﹤0.01% | 5483 |
|
|
2024
Q4 | $2.39M | Sell |
6,780
-12,656
| -65% | -$4.65M | ﹤0.01% | 4904 |
|
|
2024
Q3 | $6.96M | Buy |
19,436
+3,028
| +18% | +$1.02M | ﹤0.01% | 3099 |
|
|
2024
Q2 | $5.23M | Sell |
16,408
-18,273
| -53% | -$4.84M | ﹤0.01% | 3366 |
|
|
2024
Q1 | $7.97M | Buy |
34,681
+13,242
| +62% | +$2.99M | ﹤0.01% | 2948 |
|
|
2023
Q4 | $4.71M | Sell |
21,439
-42,100
| -66% | -$9.7M | ﹤0.01% | 3804 |
|
|
2023
Q3 | $14.4M | Buy |
63,539
+5,686
| +10% | +$1.31M | ﹤0.01% | 2121 |
|
|
2023
Q2 | $12.8M | Sell |
57,853
-29,731
| -34% | -$6.59M | ﹤0.01% | 2211 |
|
|
2023
Q1 | $19.6M | Buy |
87,584
+61,403
| +235% | +$15.1M | ﹤0.01% | 1727 |
|
|
2022
Q4 | $7.28M | Sell |
26,181
-7,417
| -22% | -$1.87M | ﹤0.01% | 2703 |
|
|
2022
Q3 | $7.04M | Buy |
33,598
+31,889
| +1,866% | +$7.13M | ﹤0.01% | 2653 |
|
|
2022
Q2 | $403K | Sell |
1,709
-6,006
| -78% | -$1.22M | ﹤0.01% | 8795 |
|
|
2022
Q1 | $1.38M | Sell |
7,715
-2,573
| -25% | -$490K | ﹤0.01% | 6341 |
|
|
2021
Q4 | $2.22M | Sell |
10,288
-38,963
| -79% | -$7.65M | ﹤0.01% | 5267 |
|
|
2021
Q3 | $9.09M | Buy |
49,251
+42,419
| +621% | +$8.36M | ﹤0.01% | 3009 |
|
|
2021
Q2 | $1.23M | Sell |
6,832
-26,952
| -80% | -$5.13M | ﹤0.01% | 7181 |
|
|
2021
Q1 | $5.65M | Buy |
33,784
+8,875
| +36% | +$1.48M | ﹤0.01% | 3673 |
|
|
2020
Q4 | $3.78M | Buy |
24,909
+15,992
| +179% | +$2.1M | ﹤0.01% | 3918 |
|
|
2020
Q3 | $901K | Buy |
8,917
+2,057
| +30% | +$226K | ﹤0.01% | 6365 |
|
|
2020
Q2 | $830K | Sell |
6,860
-8,108
| -54% | -$912K | ﹤0.01% | 6310 |
|
|
2020
Q1 | $1.42M | Sell |
14,968
-10,234
| -41% | -$973K | ﹤0.01% | 4608 |
|
|
2019
Q4 | $2.22M | Sell |
25,202
-42,516
| -63% | -$3.74M | ﹤0.01% | 4143 |
|
|
2019
Q3 | $5.4M | Buy |
67,718
+19,931
| +42% | +$1.61M | ﹤0.01% | 2617 |
|
|
2019
Q2 | $3.73M | Buy |
+47,787
| New | +$4.47M | ﹤0.01% | 3125 |
|
|
2018
Q1 | – | Sell |
-71,739
| Closed | -$9.11M | – | 10235 |
|
|
2017
Q4 | $10.6M | Buy |
+71,739
| New | +$9.12M | ﹤0.01% | 1776 |
|
|
2016
Q4 | – | Sell |
-2,679
| Closed | -$342K | – | 10194 |
|
|
2016
Q3 | $316K | Buy |
+2,679
| New | +$322K | ﹤0.01% | 6846 |
|
|
2016
Q2 | – | Sell |
-50,348
| Closed | -$5.62M | – | 9374 |
|
|
2016
Q1 | $5.61M | Buy |
+50,348
| New | +$6.37M | ﹤0.01% | 2155 |
|
|
2015
Q4 | – | Sell |
-46,731
| Closed | -$6.8M | – | 10022 |
|
|
2015
Q3 | $6.13M | Buy |
46,731
+41,931
| +874% | +$6.73M | ﹤0.01% | 2397 |
|
|
2015
Q2 | $835K | Sell |
4,800
-111
| -2% | -$20K | ﹤0.01% | 6594 |
|
|
2015
Q1 | $847K | Sell |
4,911
-47,465
| -91% | -$7.24M | ﹤0.01% | 6095 |
|
|
2014
Q4 | $6.78M | Buy |
52,376
+41,391
| +377% | +$5.33M | ﹤0.01% | 2463 |
|
|
2014
Q3 | $1.41M | Sell |
10,985
-62,589
| -85% | -$6.45M | ﹤0.01% | 5254 |
|
|
2014
Q2 | $6.51M | Sell |
73,574
-83,071
| -53% | -$7.99M | ﹤0.01% | 2677 |
|
|
2014
Q1 | $14.7M | Sell |
156,645
-26,529
| -14% | -$2.71M | 0.01% | 1574 |
|
|
2013
Q4 | $20.7M | Sell |
183,174
-52,500
| -22% | -$4.73M | 0.01% | 1322 |
|
|
2013
Q3 | $18.6M | Buy |
235,674
+4,532
| +2% | +$331K | 0.01% | 1271 |
|
|
2013
Q2 | $15.2M | Buy |
+231,142
| New | +$14.9M | 0.01% | 1368 |
|
Other funds holding UTHR
ACA
JT
Jeff Yass's UTHR Position: Q2 2026 in Review
Jeff Yass increased its United Therapeutics (UTHR) stake by 198% in Q2 2026, buying an estimated $33.2M and bringing the position to 88,579 shares worth $48M. The position accounts for ﹤0.01% of the portfolio, ranked #1543.
Jeff Yass first reported a position in UTHR in Q2 2013 and has held it in 42 quarters since. The position peaked at $74M in Q3 2025. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.
- Jeff Yass held 88,579 shares of United Therapeutics worth $48M as of Q2 2026.
- Jeff Yass bought 58,883 United Therapeutics shares in Q2 2026, an estimated $33.2M.
- United Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #1543 holding.
- Jeff Yass first reported a position in United Therapeutics in Q2 2013 and has held it in 42 quarters since.
- Jeff Yass's United Therapeutics position peaked at $74M in Q3 2025.
- 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.
Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.